We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients

News   Feb 17, 2010

 
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
 
 
 

RELATED ARTICLES

Gene Medication to Treat Spinal Cord Injury

News

After several months of gene medication treatment, rodents were able to use previously paralyzed limbs, a study has found.

READ MORE

Painkillers During Pregnancy Unlikely to Cause Asthma in Children

News

A Queen Mary University of London study of almost 500,000 women indicates that taking paracetamol or other painkillers during pregnancy is not responsible for increasing the risk of asthma in children.

READ MORE

Hematopoietic Stem Cells: Making Blood Thicker Than Water

News

Understanding how balance is maintained between self-renewal and differentiation of stem cells may provide insights relevant for leukemia research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE